Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Hao Zhang(Northwestern Polytechnical University), Quan Cheng(Central South University), Wantao Wu(Central South University), Wenjing Zeng(Central South University), Nan Zhang(Huazhong University of Science and Technology), Zeyu Wang(Anhui University), Liyang Zhang(Central South University), Zhixiong Liu(Central South University), Ziyu Dai(Central South University)
Cited by 535
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
|Journal of Hematology & Oncology|2020|400